Skip to main content
Signal8

Burnell Thomas W.

SEC insider (Form 3/4/5 filer). CIK 0001720219. CEO, President & Chairman at INTERPACE BIOSCIENCES, INC. (IDXG). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in PARSIPPANY, NJ.

Companies Burnell Thomas W. has filed insider reports for

  • INTERPACE BIOSCIENCES, INC. (IDXG): Director, Officer, CEO, President & Chairman
Burnell Thomas W. profile photo

Burnell Thomas W.

CIK: 0001720219

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INTERPACE BIOSCIENCES, INC. logo
IDXG

INTERPACE BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • INTERPACE BIOSCIENCES, INC. logo
    IDXG

    INTERPACE BIOSCIENCES, INC.

    Aug 20, 2026
    Exercise
    Direct
    2M shares-
  • INTERPACE BIOSCIENCES, INC. logo
    IDXG

    INTERPACE BIOSCIENCES, INC.

    Aug 20, 2026
    Tax Payment
    Direct
    581.7K shares at avg. $1.61$937K
  • INTERPACE BIOSCIENCES, INC. logo
    IDXG

    INTERPACE BIOSCIENCES, INC.

    Aug 20, 2026
    Award

    Restricted Stock Units

    Direct
    2M shares-
  • INTERPACE BIOSCIENCES, INC. logo
    IDXG

    INTERPACE BIOSCIENCES, INC.

    Aug 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    554K shares-

1-4 of 4